• Duration of disease-modifying treatment impacts disability outcomes in MS

    2 days ago - By Healio

    Longer exposure to disease-modifying treatment delayed the time to wheelchair use among patients with primary progressive MS, or PPMS, according to findings presented at MSVirtual2020.
    Additionally, treating younger patients - and a decrease in the delay of time to treatment - improved patients' long-term disability outcomes, study findings showed.
    “Previous phase 3 randomized, controlled trials and real-world studies largely failed to find benefit of disease-modifying drugs among patients affected by primary progressive MS,” Mattia Fonderico, a PhD candidate at
    Read more ...